New Zealand Consumer Durables Stock News

ikeGPS Group (NZSE:IKE) has posted its FY 2026 first half numbers with revenue of NZ$12.8 million and a loss of NZ$4.4 million, equivalent to EPS of NZ$0.03. The company has seen revenue move from NZ$12.2 million in the first half of FY 2025 to NZ$12.8 million in the first half of FY 2026, while losses shifted from NZ$7.1 million to NZ$4.4 million over the same periods, setting up a results season where investors are watching how quickly the loss profile could narrow. With the stock trading...

Green Cross Health (NZSE:GXH) has kicked off FY 2026 with first half revenue of NZ$264.4 million and basic EPS of NZ$0.05, set against trailing 12 month revenue of NZ$546.0 million and EPS of NZ$0.1419 that reflects 27.7% year on year earnings growth and a net profit margin of 3.7%. Over the past two reported half years, revenue has moved from NZ$259.9 million in 1H FY 2025 to NZ$263.9 million in 2H FY 2025 and now NZ$264.4 million in 1H FY 2026, while basic EPS has shifted from NZ$0.0393 to...

Mainfreight (NZSE:MFT) has opened FY 2026 with first half revenue of NZ$2.6b and basic EPS of NZ$0.93, setting the tone for how its freight and logistics operations are translating into earnings power. The company has seen revenue move from NZ$2.6b in 1H FY 2025 to NZ$2.7b in 2H FY 2025 and NZ$2.6b in 1H FY 2026, while EPS shifted from NZ$1.14 to NZ$1.59 over FY 2025 halves before landing at NZ$0.93 in the latest period. This gives investors a clearer view of how volumes and pricing are...

Readers hoping to buy My Food Bag Group Limited ( NZSE:MFB ) for its dividend will need to make their move shortly, as...

Following the solid earnings report from AFT Pharmaceuticals Limited ( NZSE:AFT ), the market responded by bidding up...

Stride Property Group (NZSE:SPG) has reported FY 2026 first half revenue of NZ$71.3 million and basic EPS of NZ$0.076, against a backdrop where trailing 12 month revenue sits at NZ$111.4 million and basic EPS at NZ$0.0559. Earnings for that period are said to have grown 44.4% year over year despite a NZ$37.1 million one off loss. Over recent halves the company has seen revenue move from NZ$62.5 million and EPS of NZ$0.033 in FY 2025 H1 to NZ$76.1 million and EPS of NZ$0.0057 in FY 2025 H2...

Mainfreight (NZSE:MFT) has released full year results to March 31, 2026, reporting sales of NZ$5,383.52m and net income of NZ$251m, prompting investors to reassess the trade off between growth and profitability. See our latest analysis for Mainfreight. Following the results, Mainfreight's share price has moved to NZ$64.75, with a 7 day share price return of 11.39% and a 30 day share price return of 10.68%. The 1 year total shareholder return has declined 5.02%, which points to improving short...

Why Ryman Healthcare’s latest earnings are back in focus Ryman Healthcare (NZSE:RYM) has moved back onto investor watchlists after releasing full year results that combined higher revenue, a smaller reported net loss and positive free cash flow for the first time in over a decade. See our latest analysis for Ryman Healthcare. The NZ$2.28 share price has seen a sharp 7 day share price return of 11.22% and a 30 day share price return of 5.07%. However, this sits against a year to date share...

It's been a pretty great week for Fisher & Paykel Healthcare Corporation Limited ( NZSE:FPH ) shareholders, with its...

Shareholders in Infratil Limited ( NZSE:IFT ) may be thrilled to learn that the analysts have just delivered a major...

Insiders who bought NZ$500.0k worth of Me Today Limited ( NZSE:MEE ) stock in the last year have seen some of their...

Ryman Healthcare (NZSE:RYM) has reported its FY 2026 first half with revenue of NZ$413.5 million and a basic EPS loss of NZ$0.04, while trailing 12 month figures show revenue of NZ$855.6 million and a basic EPS loss of NZ$0.17 as the company works through a period of weaker profitability. The company has seen revenue move from NZ$365.2 million in the first half of FY 2025 to NZ$394.0 million in the second half and now NZ$413.5 million in the first half of FY 2026, with EPS swinging from a...

In recent weeks, the global market landscape has been characterized by a strong performance in small-cap and value stocks, outpacing their large-cap counterparts amid rising inflation concerns and geopolitical tensions. As investors navigate these dynamic conditions, identifying promising opportunities within the small-cap sector can be particularly rewarding, especially when considering companies that exhibit robust insider buying activity. In this context, evaluating factors such as...

Goodman Property Trust (NZSE:GNZ) has just reported its FY 2026 first half results, with revenue of NZ$143.7 million and basic EPS of NZ$0.040161, while the trailing twelve months show revenue of NZ$286.8 million and EPS of NZ$0.081817. Over recent periods, the trust has seen revenue range from NZ$134.8 million to NZ$143.7 million per half year, alongside EPS moving between NZ$0.029568 and NZ$0.041655. This gives investors a clearer view of how income and distributions are tracking. With net...

New Zealand King Salmon Investments Limited ( NZSE:NZK ), might not be a large cap stock, but it led the NZSE gainers...

Fisher & Paykel Healthcare (NZSE:FPH) has opened FY 2026 with first half revenue of NZ$1.1b and basic EPS of NZ$0.36, setting the tone for investors focused on how its profit engine is tracking. The company has seen revenue move from NZ$951.2m and EPS of NZ$0.26 in the first half of FY 2025 to NZ$1.1b and EPS of NZ$0.36 in the latest half, with trailing 12 month EPS reaching NZ$0.80 alongside a net profit margin of 20.2% versus 9.4% a year earlier. This puts profitability firmly in focus as...

Infratil (NZSE:IFT) has opened FY 2026 with first half revenue of NZ$1.99b and basic EPS of NZ$0.33, putting fresh earnings figures in front of investors at a current share price of NZ$15.17. The company has seen revenue move from NZ$1.48b in the first half of FY 2025 to NZ$1.99b in the first half of FY 2026, while basic EPS has shifted from a loss of NZ$0.29 to a profit of NZ$0.33. This frames a clear swing in per share results. Overall, the latest numbers point to firmer margins, with...

EROAD (NZSE:ERD) has just posted its FY 2026 first half numbers, with revenue of NZ$99.1 million and a reported loss of NZ$144.2 million, which translated into EPS of NZ$0.77 loss per share. Over recent periods, revenue has moved from NZ$95.9 million in FY 2025 first half to NZ$98.5 million in FY 2025 second half and NZ$99.1 million in FY 2026 first half, while EPS has ranged from a loss of NZ$0.01 per share in FY 2025 first half to a profit of NZ$0.02 per share in FY 2025 second half before...

Pacific Edge (NZSE:PEB) has opened FY 2026 with first half revenue of NZ$6.8 million and a basic EPS loss of NZ$0.022, while trailing twelve month revenue sits at NZ$13.6 million against a trailing loss of NZ$35.8 million. Over recent half year periods, the company has reported revenue of NZ$11.3 million and NZ$11.4 million in FY 2025 halves with basic EPS losses of NZ$0.018 and NZ$0.018872. This gives investors a view of a business still working to narrow substantial losses at a current...

Auckland International Airport (NZSE:AIA) has released fresh operating data for April 2026, with updated passenger and aircraft movement figures across its Auckland and Queenstown operations that give investors a current read on travel demand. See our latest analysis for Auckland International Airport. The latest traffic figures come as Auckland International Airport's share price sits at NZ$8.27, with a 1-day share price return of 1.85% but a 90-day share price return that has declined...

We note that the Radius Residential Care Limited ( NZSE:RAD ) Independent Director, Bret Jackson, recently sold NZ$164k...

Oceania Healthcare (NZSE:OCA) has reported FY 2026 first half revenue of NZ$131.6 million with basic EPS of NZ$0.0068, setting a measured tone for its latest earnings update. The company has seen half-year revenue move between NZ$132.6 million and NZ$127.9 million over FY 2025, with basic EPS ranging from a loss of NZ$0.0236 to a profit of NZ$0.0656, giving investors a mixed earnings backdrop against which to judge the current report. With trailing 12 month net profit margins sitting near...

AFT Pharmaceuticals (NZSE:AFT) has opened FY 2026 with first half revenue of NZ$114.9 million and basic EPS of NZ$0.03, putting fresh numbers on the table for investors following its growth story. The company has seen revenue move from NZ$86.7 million and basic EPS of a NZ$0.02 loss in the first half of FY 2025 to NZ$121.3 million and basic EPS of NZ$0.14 in the second half of FY 2025, with trailing 12 month EPS most recently sitting at NZ$0.14 on revenue of NZ$254.7 million and net income of...

It's been a pretty great week for AFT Pharmaceuticals Limited ( NZSE:AFT ) shareholders, with its shares surging 11% to...